Home › Bayer clotting drug meets late-stage study's goal
 

Keywords :   


Bayer clotting drug meets late-stage study's goal

2014-02-19 03:22:29| Chemicals - Topix.net

Bayer HealthCare Pharmaceuticals said Tuesday that its experimental, genetically engineered treatment for the most common type of bleeding disorder hemophilia met its main goal of reducing treatment frequency in a late-stage patient study.

Tags: goal drug meets bayer

Category:Chemicals

Latest from this category

All news
01.11BASF TotalEnergies Petrochemicals Receives United Way Champions of Hope Award
31.10Nippon Paint Holdings to Acquire AOC from Lone Star Funds
31.10RPM Acquires TMP Convert
31.10AkzoNobels Largest European Solar Energy Plant Goes Live in Poland
30.10BASF Groups EBITDA Before Special Items Up from Q3 2023
30.10Axalta Reports Record Net Sales in 3Q 2024
30.10Zack Hays Joins Orion S.A. as Marketing Manager
30.10UK Linseed Paint Maker Launches US Venture
Chemicals »
02.11Tropical Depression Thirteen-E Graphics
02.11Summary for Tropical Depression Thirteen-E (EP3/EP132024)
02.11Fragrancing Spaces with Atmos, A Smart Home Diffuser
02.11Eastern North Pacific Tropical Weather Outlook
02.11Atlantic Tropical Weather Outlook
01.11Tropical Depression Thirteen-E Forecast Discussion Number 1
01.11Tropical Depression Thirteen-E Graphics
01.11Tropical Depression Thirteen-E Wind Speed Probabilities Number 1
More »